MedTrace Logo

CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients

NCT00365833 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2011-09-30

No results posted yet for this study

Summary

We believe that certain cells in the human body (Circulating Endothelial Cells and Endothelial Progenitor Cells) are related to risk of cardiovascular disease. It may be possible to measure levels of these cells in patients who have had a kidney transplant and predict their risk of developing cardiovascular disease.

Conditions

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Herwig-Ulf Meier-Kriesche, md · University of Florida

  • Giselle Guerra, MD · University of Florida

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2007-02-28
Completion
2007-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00365833 on ClinicalTrials.gov